Loading...
OTCM
MDVLQ
Market cap0kUSD
Jan 31, Last price  
0.00USD
Name

MYOS RENS Technology Inc

Chart & Performance

D1W1MN
P/E
—
P/S
0.00
EPS
—
Div Yield, %
—
Shrs. gr., 5y
62.11%
Rev. gr., 5y
141.39%
Revenues
43m
+94.81%
000099,475911,7273,317,8853,343,000159,000327,000526,000360,0003,771,00013,968,00022,129,00043,109,000
Net income
-48m
L+8.68%
00-39,308-16,525-5,597,300-3,914,460-4,262,796-5,207,000-5,074,000-4,341,000-4,058,000-3,223,000-22,267,000-26,136,000-43,815,000-47,616,000
CFO
-48m
L+12.10%
00-36,090-2,155,733-2,345,7070-5,089,000-2,252,000-3,673,000-3,783,000-3,250,000-19,546,000-28,634,000-42,519,000-47,664,000

Profile

MedAvail Holdings, Inc., a technology-enabled retail pharmacy technology and services company, develops and commercializes self-service pharmacy, mobile application, kiosk, and drive-thru solutions in the United States and Canada. It operates in two segments, Retail Pharmacy Services and Pharmacy Technology. The company's MedCenter enables on-site pharmacy in medical clinics, retail store locations, employer sites with and without onsite clinics, and other location where onsite prescription dispensing is desired, as well as establishes an audio-visual connection to a live pharmacist enabling prescription drug dispensing to occur directly to a patient with real-time supervision by a pharmacist. It also owns and operates SpotRx, a retail pharmacy platform. As of December 31, 2021, the company had 81 MedCenter kiosks. MedAvail Holdings, Inc. is headquartered in Mississauga, Canada.
URL
https://investors.medavail.com/overview/default.aspx
IPO date
Oct 20, 2008
Employees
279
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
43,109
94.81%
Cost of revenue
73,624
Unusual Expense (Income)
NOPBT
(30,515)
NOPBT Margin
Operating Taxes
24
Tax Rate
NOPAT
(30,539)
Net income
(47,616)
8.68%
Dividends
Dividend yield
Proceeds from repurchase of equity
46,962
BB yield
-11,907.34%
Debt
Debt current
708
Long-term debt
8,644
Deferred revenue
Other long-term liabilities
Net debt
(2,092)
Cash flow
Cash from operating activities
(47,664)
CAPEX
(2,304)
Cash from investing activities
(2,274)
Cash from financing activities
41,969
FCF
(36,952)
Balance
Cash
11,444
Long term investments
Excess cash
9,289
Stockholders' equity
(246,553)
Invested Capital
274,452
ROIC
ROCE
EV
Common stock shares outstanding
1,316
Price
0.30
-78.59%
Market cap
394
-56.87%
EV
(1,698)
EBITDA
(25,860)
EV/EBITDA
0.07
Interest
1,172
Interest/NOPBT